This authoritative volume in the Diagnostic Pathology series serves as an invaluable point-of-care resource for practitioners of all levels of experience and training. Encompassing a wide spectrum of nonneoplastic and neoplastic conditions affecting blood and bone marrow, the third edition integrates the latest scientific and technical knowledge to provide a comprehensive overview of all pivotal aspects relevant to contemporary medical practice. With a wealth of illustrations and user-friendly features, “Diagnostic Pathology: Blood and Bone Marrow” is an essential reference for pathologists, hematopathologists, oncologists, hematologists, residents, students, and fellows.
Key Features:
Comprehensive Coverage: Addresses a broad range of nonneoplastic and neoplastic conditions of blood and bone marrow, delivering crucial information on new entities, recently identified causes of morphologic abnormalities, and updated diagnostic strategies. Emphasis is placed on key tests and vital considerations in differential diagnosis.
Identification of Unique Findings: Aids pathologists in recognizing distinctive blood and bone marrow findings that can indicate specific exposures, such as emerging medications, targeted therapies, or toxins.
Integration of Updated Knowledge: Incorporates the latest technologies, newly recognized disorders, complications/features in blood and bone marrow, targeted therapies, and the increasing use of homeopathic remedies.
New Chapters: Introduces new chapters covering various topics, including SARS-CoV-2 infection features in blood and bone marrow, myelodysplastic syndrome (MDS) mimics, blood and bone marrow findings associated with targeted therapies, blood and bone marrow findings related to other medications, and more.
Updates and Expansions: Updates existing chapters and expands information on T-cell neoplasms in blood and bone marrow and intravascular large B-cell lymphoma in blood and bone marrow.
Incorporation of Latest Classification Systems: Includes content from the World Health Organization (WHO) fifth edition Classification of Haematolymphoid Tumours and the most recent 2023 International Consensus Classification (ICC) publications. This reflects updates on diagnostic entities, tumor classifications, terminology changes, and more.
Molecular Testing Strategies: Discusses molecular testing strategies tailored to specific neoplasms and differential diagnostic considerations.
Genetic Disorders: Clearly delineates numerous genetic disorders commonly encountered in blood and bone marrow.
Rich Visual Content: Features over 2,500 high-quality images, including histology and gross pathology photographs, full-color illustrations, clinical images, radiologic pictures, tables, charts, and algorithms.
User-Friendly Format: Utilizes consistently templated chapters, bulleted content, key facts, various tables, annotated images, pertinent references, and an extensive index, ensuring swift and expert reference at the point of care.
“Diagnostic Pathology: Blood and Bone Marrow” is a vital resource that meets the diverse needs of healthcare professionals, serving as an indispensable daily reference and a dependable training tool.
